Immunome, Inc. (IMNM)
24.93
+0.43
(+1.76%)
USD |
NASDAQ |
Feb 10, 16:00
24.93
0.00 (0.00%)
Pre-Market: 20:00
Immunome EPS Diluted (Quarterly) : -0.6532 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Prelude Therapeutics, Inc. | -0.2591 |
| Eli Lilly & Co. | 7.390 |
| Relay Therapeutics, Inc. | -0.4301 |
| Context Therapeutics, Inc. | -0.1018 |
| Moderna, Inc. | -0.5128 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -57.46M |
| Total Expenses (Quarterly) | 57.46M |
| Enterprise Value | 2.018B |
| Earnings Yield | -11.86% |
| Normalized Earnings Yield | -10.63 |